The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan

References

• Mueller N. The epidemiology of HTLV-I infection. Cancer Causes Control 1991;2:37–52.
   PubMed Web of Science ®Google Scholar
• Manns A, Blattner WA. The epidemiology of the human T-cell lymphotrophic virus type I and type II:etiologic role in human disease. Transfusion 1991;31:67–75.
   PubMed Web of Science ®Google Scholar
• Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan:estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990;45:237–243.
   PubMed Web of Science ®Google Scholar
• The T- and B-cell Malignancy Study Group; Hirose K, Tajima K. The 9th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan. Jpn J Cancer Clin 2001;47:341–357. [Japanese]
   Google Scholar
• Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol 2012;84:327–335.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Atogami S, Hasegawa H, et al. Nationwide survey of adult T-cell leukemia/lymphoma (ATL) in Japan. Rinsho Ketsueki 2011;52:1765–1771. [Japanese]
   PubMedGoogle Scholar
• Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia. Front Microbiol 2012;3:334.
   Google Scholar
• Lairmore MD, Haines R, Anupam R. Mechanisms of human T-lymphotropic virus type 1 transmission and disease. Curr Opin Virol 2012;2:474–481.
   Web of Science ®Google Scholar
• Hino S. Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:152–166.
   PubMed Web of Science ®Google Scholar
• Hino S, Sugiyama H, Doi H, et al. Breaking the cycle of HTLV-I transmission via carrier mothers’ milk. Lancet 1987;2:158–159.
   PubMed Web of Science ®Google Scholar
• Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000;50: 696–702.
   PubMed Web of Science ®Google Scholar
• Aoki R, Karube K, Sugita Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006. Pathol Int 2008;58:174–182.
   PubMed Web of Science ®Google Scholar
• Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989;43:250–253.
   PubMed Web of Science ®Google Scholar
• Cleghorn FR, Manns A, Falk R, et al. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Cancer Inst 1995;87:1009–1014.
   PubMed Web of Science ®Google Scholar
• Tajima K, Tominaga S, Suchi T, et al. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Jpn J Cancer Res 1982;73:893–901.
   Google Scholar
• Kajiyama W, Kashiwagi S, Ikematsu H, et al. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 1986;154: 851–857.
   PubMed Web of Science ®Google Scholar
• Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989;111:555–560.
   PubMed Web of Science ®Google Scholar
• Death rates by sex, age and causes (the condensed list of causes of death for Japan). Available from: www.e-stat.go.jp/SG1/estat/GL08020102.do?_toGL08020102_&tclassID =000001041668&cycleCode = 7&requestSender = dsearch
   Google Scholar
• Eguchi K, Fujii H, Oshima K, et al. Human T-lymphotropic virus type 1 (HTLV-1) genetic typing in Kakeroma island, an island at the crossroads of the Ryukyuans and Wajin in Japan, providing further insights into the origin of the virus in Japan. J Med Virol 2009;81:1450–1456.
   PubMed Web of Science ®Google Scholar
• Otani M, Honda N, Xia PC, et al. Distribution of two subgroups of human T-lymphotropic virus type 1 (HTLV-1) in endemic Japan. Trop Med Health 2012;40:55–58.
   Google Scholar
• Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I/II and associated diseases. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl. 1):S119–S123.
   Google Scholar
• Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058–6068.
   PubMed Web of Science ®Google Scholar
• Birmann BM, Breen EC, Stuver S, et al. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica. Int J Cancer 2009;124: 614–621.
   PubMed Web of Science ®Google Scholar
• Yamaguchi-Kabata Y, Nakazono K, Takahashi A, et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 2008;83:445–456.
   PubMed Web of Science ®Google Scholar
• HUGO Pan-Asian SNP Consortium; Abdulla MA, Ahmed I, Assawamakin A, et al.; Indian Genome Variation Consortium. Mapping human genetic diversity in Asia. Science 2009;326:1541–1545.
   PubMed Web of Science ®Google Scholar
• Gérard Y, Lepere JF, Pradinaud R, et al. Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population* of French Guiana. Int J Cancer 1995;60:773–776.
   PubMed Web of Science ®Google Scholar
• Levine PH, Manns A, Jaffe ES, et al. The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States. Int J Cancer 1994;56:177–181.
   PubMed Web of Science ®Google Scholar
• Sonoda S, Li HC, Tajima K. Ethnoepidemiology of HTLV-1 related diseases:ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal. Cancer Sci 2011;102:295–301.
   PubMed Web of Science ®Google Scholar
• Koga Y, Iwanaga M, Soda M, et al. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan. J Med Virol 2010;82:668–674.
   PubMed Web of Science ®Google Scholar
• Hlela C, Shepperd S, Khumalo NP, et al. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev 2009;11:205–214.
   PubMed Web of Science ®Google Scholar
• Kondo T, Kono H, Miyamoto N, et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer 1989;43:1061–1064.
   PubMed Web of Science ®Google Scholar
• Tokudome S, Tokunaga O, Shimamoto Y, et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res 1989;49:226–228.
   PubMed Web of Science ®Google Scholar
• Hisada M, Stuver SO, Okayama A, et al. Gender difference in skin reactivity to purified protein derivative among carriers of HTLV-I in Japan. J Acquir Immune Defic Syndr 1999;22:302–307.
   PubMed Web of Science ®Google Scholar
• Kwaan N, Lee TH, Chafets DM, et al.; HTLV Outcomes Study (HOST) Investigators. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 2006;194:1557–1564.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Ford E, Giovino GA, et al. Lung cancer mortality rates in birth cohorts in the United States from 1960 to 1994. Lung Cancer 2001;31:91–99.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhan Z, Wu J et al. Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects. PLoS One 2013;8:e59254.
   Web of Science ®Google Scholar
• Uozumi K, Uematsu T, Otsuka M, et al. Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers. Am J Hematol 1996;53:165–168.
   PubMed Web of Science ®Google Scholar
• Los M, Khazaie K, Schulze-Osthoff K, et al. Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state. J Immunol 1998;161: 3050–3055.
   PubMed Web of Science ®Google Scholar
• Tzagarakis-Foster C, Geleziunas R, Lomri A, et al. Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription. J Biol Chem 2002;277:44772–44777.
   PubMed Web of Science ®Google Scholar
• Tajima K, Cartier L. Epidemiological features of HTLV-I and adult T cell leukemia. Intervirology 1995;38:238–246.
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009;27:453–459.
   PubMed Web of Science ®Google Scholar
• Tanosaki R, Tobinai K. Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches. Expert Rev Hematol 2010;3:743–753.
   PubMed Web of Science ®Google Scholar
• Obama K, Utsunomiya A, Takatsuka Y, et al. Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance. Bone Marrow Transplant 2004;34:897–899.
   PubMed Web of Science ®Google Scholar
• Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005;105:4143–4145.
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Tobinai K. Biology and treatment of HTLV-1 associated T-cell lymphomas. Best Pract Res Clin Haematol 2013;26: 3–14.
   PubMed Web of Science ®Google Scholar
• Hanchard B. Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995. J Acquir Immune Defic Syndr Hum Retrovirol 1996 ;13(Suppl. 1):S20–S25.
   Google Scholar
• Hisada M, Stuver SO, Okayama A, et al. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 2004;190:1605–1609.
   PubMed Web of Science ®Google Scholar
• Pombo de Oliveira MS, Matutes E, Schulz T, et al. T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer 1995;60:823–827.
   PubMed Web of Science ®Google Scholar